With 0.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.35 million shares. During the session, the Banks – Regional company that operates in wider Financial sector, reached to the highest price of $69.1499 whereas the lowest price it dropped to was $64.76. The 52-week range on BMA shows that it touched its highest point at $118.42 and its lowest point at $40.94 during that stretch. It currently has a 1-year price target of $140.59. With its current market cap of 4.10 billion, BMA has annualized dividend of $0.00 while the current yield stands at 0.00%. BMA paid its most recent dividend on 1723766400, while the ex-dividend date for that was 1723766400. Beta for the stock currently stands at 1.75.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BMA was down-trending over the past week, with a drop of -14.80%, but this was down by -18.53% over a month. Three-month performance dropped to -42.60% while six-month performance fell -3.84%. The stock gained 40.03% in the past year, while it has lost -32.47% so far this year. A look at the trailing 12-month EPS for BMA yields 4.57 with Next year EPS estimates of 14.62. For the next quarter, that number is 1.75. This implies an EPS growth rate of 115.71% for this year and 41.89% for next year. EPS is expected to grow by 51.49% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -15.97%.
Float and Shares Shorts:
At present, 62.82 million BMA shares are outstanding with a float of 62.74 million shares on hand for trading. On 2025-03-14, short shares totaled 0.45 million, which was 72.000003 higher than short shares on 1739491200. In addition to Mr. Jorge Francisco Scarinci C.F.A. as the firm’s CFO, Finance Manager & IR Manager, Mr. Gerardo Adrian Alvarez serves as its Operations & Compliance Manager.
Institutional Ownership:
Through their ownership of 0.12362 of BMA’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BMA since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With BMA analysts setting a high price target of 155.88452 and a low target of 75.904045, the average target price over the next 12 months is 115.023445. Based on these targets, BMA could surge 138.57% to reach the target high and rise by 16.17% to reach the target low. Reaching the average price target will result in a growth of 76.04% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $5519.87688 being high and $3979.60837 being low. For BMA, this leads to a yearly average estimate of $4730.91669. Based on analyst estimates, the high estimate for the next quarter is $2408.7 and the low estimate is $2408.7. The average estimate for the next quarter is thus $2408.7.
